Moxyplant CV 457 dry syrup is a potent, broad-spectrum antibiotic formulation specifically designed for pediatric use. It contains a synergistic combination of Amoxycillin, a beta-lactam antibiotic, and Clavulanic Acid, a beta-lactamase inhibitor. This powerful duo effectively combats a wide range of bacterial infections by not only killing bacteria but also preventing bacterial resistance to amoxycillin.
Amoxycillin interferes with bacterial cell wall synthesis, resulting in bacterial death. Clavulanic Acid enhances this effect by inhibiting beta-lactamase enzymes produced by resistant bacteria, thereby restoring the activity of amoxycillin against resistant strains. The combination is particularly effective against respiratory tract infections, otitis media, sinusitis, skin and soft tissue infections, and urinary tract infections.
This dry syrup formulation is easy to reconstitute and administer, making it ideal for children who have difficulty swallowing tablets. The pleasant flavor ensures better compliance among pediatric patients.
Moxyplant CV 457 dry syrup should be used strictly under medical supervision. The full prescribed course must be completed to prevent relapse or resistance, even if symptoms improve early. It should not be used to treat viral infections such as the common cold or flu.